Pulskens Wilco P, Teske Gwendoline J, Butter Loes M, Roelofs Joris J, van der Poll Tom, Florquin Sandrine, Leemans Jaklien C
Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
PLoS One. 2008;3(10):e3596. doi: 10.1371/journal.pone.0003596. Epub 2008 Oct 31.
Toll-like receptors (TLRs) can detect endogenous danger molecules released upon tissue injury resulting in the induction of a proinflammatory response. One of the TLR family members, TLR4, is constitutively expressed at RNA level on renal epithelium and this expression is enhanced upon renal ischemia/reperfusion (I/R) injury. The functional relevance of this organ-specific upregulation remains however unknown. We therefore investigated the specific role of TLR4 and the relative contribution of its two downstream signaling cascades, the MyD88-dependent and TRIF-dependent cascades in renal damage by using TLR4-/-, MyD88-/- and TRIF-mutant mice that were subjected to renal ischemia/reperfusion injury. Our results show that TLR4 initiates an exaggerated proinflammatory response upon I/R injury, as reflected by lower levels of chemokines and infiltrating granulocytes, less renal damage and a more preserved renal function in TLR4-/- mice as compared to wild type mice. In vitro studies demonstrate that renal tubular epithelial cells can coordinate an immune response to ischemic injury in a TLR4-dependent manner. In vivo we found that epithelial- and leukocyte-associated functional TLR4 contribute in a similar proportion to renal dysfunction and injury as assessed by bone marrow chimeric mice. Surprisingly, no significant differences were found in renal function and inflammation in MyD88-/- and TRIF-mutant mice compared with their wild types, suggesting that selective targeting of TLR4 directly may be more effective for the development of therapeutic tools to prevent I/R injury than targeting the intracellular pathways used by TLR4. In conclusion, we identified TLR4 as a cellular sentinel for acute renal damage that subsequently controls the induction of an innate immune response.
Toll样受体(TLRs)能够检测组织损伤时释放的内源性危险分子,从而诱导促炎反应。TLR家族成员之一TLR4在肾上皮细胞的RNA水平上持续表达,并且这种表达在肾缺血/再灌注(I/R)损伤后会增强。然而,这种器官特异性上调的功能相关性尚不清楚。因此,我们通过使用遭受肾缺血/再灌注损伤的TLR4-/-、MyD88-/-和TRIF突变小鼠,研究了TLR4的具体作用及其两个下游信号级联反应(MyD88依赖和TRIF依赖级联反应)在肾损伤中的相对贡献。我们的结果表明,与野生型小鼠相比,TLR4-/-小鼠在I/R损伤后引发过度的促炎反应,表现为趋化因子水平降低、浸润性粒细胞减少、肾损伤减轻以及肾功能更易保留。体外研究表明,肾小管上皮细胞能够以TLR4依赖的方式协调对缺血损伤的免疫反应。在体内,我们发现通过骨髓嵌合小鼠评估,上皮细胞和白细胞相关的功能性TLR4对肾功能障碍和损伤的贡献比例相似。令人惊讶的是,与野生型相比,MyD88-/-和TRIF突变小鼠在肾功能和炎症方面没有显著差异,这表明直接选择性靶向TLR4可能比靶向TLR4使用的细胞内途径更有效地开发预防I/R损伤的治疗工具。总之,我们确定TLR4是急性肾损伤的细胞哨兵,随后控制先天性免疫反应的诱导。